Rafferty Asset Management
LGND icon

Rafferty Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Rafferty Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,270
Closed -$240K – 1110
2025
Q4 		$240K Sell
1,270
-33
-3% -$6.34K ﹤0.01% 1040
2025
Q3 		$231K Buy
+1,303
New +$194K ﹤0.01% 1045
2022
Q4 		– Sell
-58,237
Closed -$3.13M – 1136
2022
Q3 		$3.13M Buy
58,237
+13,327
+30% +$783K 0.03% 408
2022
Q2 		$2.5M Sell
44,910
-31,745
-41% -$1.8M 0.02% 421
2022
Q1 		$5.38M Buy
76,655
+17,932
+31% +$1.3M 0.03% 374
2021
Q4 		$5.66M Buy
58,723
+22,229
+61% +$2.05M 0.03% 337
2021
Q3 		$3.17M Buy
36,494
+2,669
+8% +$206K 0.02% 446
2021
Q2 		$2.77M Buy
33,825
+1,417
+4% +$118K 0.02% 533
2021
Q1 		$3.08M Buy
32,408
+16,312
+101% +$1.54M 0.02% 470
2020
Q4 		$999K Sell
16,096
-15,158
-48% -$864K 0.01% 493
2020
Q3 		$1.86M Buy
31,254
+16,037
+105% +$1.09M 0.02% 440
2020
Q2 		$1.06M Buy
15,217
+8,242
+118% +$523K 0.02% 527
2020
Q1 		$316K Sell
6,975
-52,334
-88% -$2.97M 0.01% 422
2019
Q4 		$3.86M Sell
59,309
-47,335
-44% -$3.16M 0.06% 171
2019
Q3 		$6.62M Buy
106,644
+29,128
+38% +$1.83M 0.1% 111
2019
Q2 		$5.52M Buy
77,516
+2,468
+3% +$182K 0.1% 140
2019
Q1 		$5.88M Buy
+75,048
New +$5.69M 0.09% 112

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Rafferty Asset Management's LGND Position: Q1 2026 in Review

Rafferty Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 1,270 shares — an estimated $240K sold.

Rafferty Asset Management first reported a position in LGND in Q1 2019 and held it in 17 quarters. The position peaked at $6.62M in Q3 2019. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Rafferty Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 1,270 Ligand Pharmaceuticals shares in Q1 2026, an estimated $240K.
  • Rafferty Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 17 quarters.
  • Rafferty Asset Management's Ligand Pharmaceuticals position peaked at $6.62M in Q3 2019.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.